StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.72−0.04 (-4.65%)

Close on Nov 17, 2026Market cap $8.33MP/E –Yield –

Phio Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Phio Pharmaceuticals's market cap was $9.45M on Nov 11, 2026, against $7.29M a year earlier. Over the last 5 years it ranged from $1.37M to $14.17M, with a median of $6.40M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.45M+55.5%
2025Dec 31, 2025$6.07M+252.2%
2024Dec 31, 2024$1.72M-1.6%
2023Dec 29, 2023$1.75M-65.5%
2022Dec 30, 2022$5.08M-62.4%
2021Dec 31, 2021$13.54M-13.0%
2020Dec 31, 2020$15.55M+254.4%
2019Dec 31, 2019$4.39M+198.9%
2018Dec 31, 2018$1.47M-88.9%
2017Dec 29, 2017$13.17M+179.5%
2016Dec 30, 2016$4.71M-80.9%
2015Dec 31, 2015$24.73M-27.7%
2014Dec 31, 2014$34.21M-0.7%
2013Dec 31, 2013$34.45M+329.6%
2012Dec 31, 2012$8.02M–

More Phio Pharmaceuticals figures

See a number that looks wrong?